ReviewAsian journal of pharmaceutical sciences2024

Biopharmaceutical and pharmacokinetic attributes to drive nanoformulations of small molecule tyrosine kinase inhibitors.

Soumyadip Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.